← FDA Drug Approvals (Drugs@FDA)

TAZIDIME

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LILLY · Approved 1985-11-20

Drug application

FDA Application #

ANDA062655

Application type

Abbreviated New Drug Application (Generic)

Brand name

TAZIDIME

Generic name

Ceftazidime

Active ingredients

CEFTAZIDIME

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

LILLY

First approval

1985-11-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown